BODIPY nanoparticles functionalized with lactose for cancer-targeted and fluorescence imaging-guided photodynamic therapy

A series of four lactose-modified BODIPY photosensitizers (PSs) with different substituents (-I, -H, -OCH3, and -NO2) in the para-phenyl moiety attached to the meso-position of the BODIPY core were synthesized; the photophysical properties and photodynamic anticancer activities of these sensitizers were investigated, focusing on the electronic properties of the different substituent groups. Compared to parent BODIPY H, iodine substitution (BODIPY I) enhanced the intersystem crossing (ISC) to produce singlet oxygen (O-1(2)) due to the heavy atom effect, and maintained a high fluorescence quantum yield (phi(F)) of 0.45. Substitution with the electron-donating methoxy group (BODIPY OMe) results in a significant perturbation of occupied frontier molecular orbitals and consequently achieves higher O-1(2) generation capability with a high phi(F) of 0.49, while substitution with the electron-withdrawing nitro group (BODIPY NO2) led a perturbation of unoccupied frontier molecular orbitals and induces a forbidden dark S-1 state, which is negative for both fluorescence and O-1(2) generation efficiencies. The BODIPY PSs formed water-soluble nanoparticles (NPs) functionalized with lactose as liver cancer-targeting ligands. BODIPY I and OMe NPs showed good fluorescence imaging and PDT activity against various tumor cells (HeLa and Huh-7 cells). Collectively, the BODIPY NPs demonstrated high O-1(2) generation capability and phi(F) may create a new opportunity to develop useful imaging-guided PDT agents for tumor cells.

Automated summary

By modifying the substituents in lactose-modified BODIPY photosensitizers, the photophysical properties and photodynamic anticancer activities of the sensitizers can be controlled. The substituents have different effects on fluorescence and singlet oxygen generation capability.